Clinical Trial Update: The Effect of AMG 133 on Gastric Emptying [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating AMG 133's effect on gastric emptying in individuals with obesity has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• AMG 133

Snippet

Sponsor: Amgen | Conditions: Overweight or Obesity | Phase 1 | Status: COMPLETED